Back to Selection     Print       Date : 30 Jun 2025
Fund Summary
Nippon India Pharma Fund (G)
[Equity: Sectoral]  
 
Fund Details
Fund Type Growth Launch Date 05-Jun-2004
Corpus(Cr.) 8569.0 Latest NAV 536.8074 As on 30-07-2025
Equity(%) 99.43 52 Week High 536.807
Debt(%) 0.57 52 Week Low 451.81
Others(%) 0.0 Exit Load -
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 1.80
Scheme Benchmark BSE Healthcare TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Sailesh Raj Bhan
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 37.90%
Top 10 Holdings 57.41%
Top 25 Holdings 90.40%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 75.69
Healthcare 19.91
Retail 3.83
Cash 0.57
 
 
 
 
 
Portfolio Metrics
PB Ratio 5.94
PE Ratio 38.93
 
Top 25 Holdings
Holdings Net Asset(%)
Sun Pharmaceutical Industries Limited 12.23
DIVI LABORATORIES LTD. 8.50
Lupin Limited 6.07
Cipla Limited 5.62
Apollo Hospitals Enterprise Limited 5.48
Dr Reddys Laboratories Limited 5.18
MedPlus Health Services Limited 3.83
Glaxosmithkline Pharma Ltd 3.63
Narayana Hrudalaya Ltd 3.55
Vijaya Diagnostic Centre Limited 3.32
Gland Pharma Limited 3.27
Ajanta Pharma Limited 2.88
Abbott India Limited 2.86
Zydus Lifesciences Limited 2.31
Sai Life Sciences Limited 2.31
Dr Lal Path Labs Ltd 2.31
Aurobindo Pharma Limited 2.25
Pfizer Limited 2.11
Mankind Pharma Limited 2.05
Thyrocare Technologies Limited 2.04
J B Chemicals and Pharma Ltd 1.96
Alkem Laboratories Limited 1.87
Sanofi India Limited 1.71
Biocon Limited 1.64
SANOFI CONSUMER HEALTHCARE 1.42

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
3.45% 8.02% 12.02% 10.90%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
-2.43% 2.80% 7.76% 1.27%
 
Scheme Benchmark [BSE Healthcare TRI]
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
25.15% 24.95% 21.24% 14.44%
 
 
13.82% 14.44% 18.90% 12.79%
 
 
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
Nippon India Pharma Fund (G) 14.75% -0.4122 13.4397% 48.8498 -0.0056
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
Nippon India Pharma Fund (G) -7.2897% 0.6808 -0.1111 15.5040 -0.6140
 
Back to Selection